Time between suspected and confirmed diagnoses of Crohn’s disease and ulcerative colitis in patients followed in gastroenterological practices in Germany
- 26 Downloads
The goal of the present study was to analyze the time between suspected and confirmed diagnoses of Crohn’s disease (CD) and ulcerative colitis (UC) in patients followed in gastroenterological practices in Germany.
The study included individuals who received a suspected diagnosis of CD or UC (index date) and were followed in 47 gastroenterological practices in Germany between January 2007 and December 2016. The main outcome measure of the study was the time between suspected and confirmed diagnoses of CD and UC. Covariables included age, sex, and type of health insurance (private or statutory). A multivariate linear regression model was used to analyze the impact of the different variables on the time between suspected and confirmed diagnoses of CD and UC.
The study included 2657 patients with a suspected diagnosis of CD and UC between 2007 and 2016. The mean age was 39.7 (SD 15.9) and 41.3 (16.8) in the CD and UC groups, respectively. Median time between suspected and confirmed diagnoses was 46 days in the CD group and 43 days in the UC group. Median time ranged from 8 to 112 days in the different gastroenterology practices and was significantly shorter in individuals with private health insurance coverage than in those with statutory health insurance.
Median time between suspected and confirmed diagnoses of CD or UC was around 45 days in patients followed in gastroenterological practices in Germany. Health insurance was the only factor to have a significant impact on this time.
KeywordsCrohn’s disease Ulcerative colitis Time between suspected and confirmed diagnoses Risk factors Gastroenterological practices
The authors have received no financial support for the research, authorship, and/or publication of this article.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, JCY W, FKL C et al (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390:2769–2778. https://doi.org/10.1016/S0140-6736(17)32448-0 CrossRefPubMedGoogle Scholar
- 4.D’Haens G, Baert F, van Assche G, Caenepeel P, Vergauwe P, Tuynman H, De Vos M, van Deventer S, Stitt L, Donner A et al (2008) Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn’s disease: an open randomised trial. Lancet Lond Engl 371:660–667. https://doi.org/10.1016/S0140-6736(08)60304-9 CrossRefGoogle Scholar
- 5.Colombel JF, Rutgeerts P, Reinisch W, Esser D, Wang Y, Lang Y, Marano CW, Strauss R, Oddens BJ, Feagan BG, Hanauer SB, Lichtenstein GR, Present D, Sands BE, Sandborn WJ (2011) Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 141:1194–1201. https://doi.org/10.1053/j.gastro.2011.06.054 CrossRefPubMedGoogle Scholar
- 6.Vavricka SR, Spigaglia SM, Rogler G, Pittet V, Michetti P, Felley C, Mottet C, Braegger CP, Rogler D, Straumann A, Bauerfeind P, Fried M, Schoepfer AM, Swiss IBD Cohort Study Group (2012) Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflamm Bowel Dis 18:496–505. https://doi.org/10.1002/ibd.21719 CrossRefPubMedGoogle Scholar
- 9.Cantoro L, Di Sabatino A, Papi C, Margagnoni G, Ardizzone S, Giuffrida P, Giannarelli D, Massari A, Monterubbianesi R, Lenti MV et al (2017) The time course of diagnostic delay in inflammatory bowel disease over the last sixty years: an Italian multicentre study. J Crohns Colitis 11:975–980. https://doi.org/10.1093/ecco-jcc/jjx041 CrossRefPubMedGoogle Scholar
- 11.Ricciuto A, Fish JR, Tomalty DE, Carman N, Crowley E, Popalis C, Muise A, Walters TD, Griffiths AM, Church PC (2017) Diagnostic delay in Canadian children with inflammatory bowel disease is more common in Crohn’s disease and associated with decreased height. Arch Dis Child. https://doi.org/10.1136/archdischild-2017-313060
- 12.Dombrowski S, Kostev K (2017) Use of electronic medical records in the epidemiological research [internet]. Cuvillier VerlagGoogle Scholar
- 15.Kostev K, Winiarski M, Schüller L, Sesterhenn AM, Jacob L (2018) Frequency of thyroid-stimulating hormone monitoring in patients after thyroidectomy: a retrospective study in primary care practices in Germany. Exp Clin Endocrinol Diabetes. https://doi.org/10.1055/s-0044-100038